4 completed, 2 unknown. 2 Phase 3, 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow cilnidipine: new trials by email Literature Review of cilnidipine trials Research Report on cilnidipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan Cilnidipine/Valsartan, Cilnidipine+Valsartan - Hypertension | Phase 1 | Completed | IlDong Pharmaceutical Co Ltd | 54 | 2015-03-01 | 2016-01-13 |
| Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg - Hypertension | Phase 3 | Completed | IlDong Pharmaceutical Co Ltd | 286 | 2014-06-17 | 2018-06-13 |
| Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) Cilnidipine, Imidapril - Kidney, Polycystic, Autosomal Dominant | Phase 2 | Unknown | Ministry of Health, Labour and Welfare, Japan | 160 | 2009-07-01 | 2009-12-02 |
| CCB Safety Study in Treatment of Hypertension of ADPKD Candesartan, Candesartan and Cilnidipine, Candesartan plus non-CCB agents - Kidney, Polycystic, Autosomal Dominant | Phase 4 | Unknown | Kyorin University | 150 | 2007-12-01 | 2007-10-18 |
| The Effects of Cilnidipine on Metabolic Syndrome Improvement Cilnidipine - Hypertension, Metabolic Syndrome X | Phase 4 | Completed | Boryung Pharmaceutical Co., Ltd | 186 | 2005-07-01 | 2008-08-27 |
| Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension cilnidipine - Hypertension, Stroke | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 250 | 2005-01-01 | 2008-12-12 |
Hypertension (6) · Polycystic Kidney, Autosomal Dominant (2) · Ischemic Stroke (1) · Metabolic Syndrome (1) · Stroke (1)
Boryung Pharmaceutical Co., Ltd (2) · IlDong Pharmaceutical Co Ltd (2) · Kyorin University (1) · Ministry of Health, Labour and Welfare, Japan (1)
South Korea (3) · Japan (2)
Dong Ju Choi, M.D., Ph.D. (1) · Dong W Kang, Assistant Professor (1) · Dong-su Kim, Ph.D. (1) · Eiji Higashihara, M.D. (1) · Heon-sik Park, Ph.D. (1) · Ho-joong Youn, Ph.D. (1) · In-ho Chae, Ph.D. (1) · Ja S Koo, Professor (1) · Jeong Bae Park, Ph.D. (1) · Jeong H Rha, Professor (1) · Ji-dong Seong, Ph.D. (1) · Keun S Hong, Professor (1) · Kyungsang Yu, PhD (1) · Sang-hyun Lim, Ph.D. (1) · Se-joong Im, Ph.D. (1)